| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.38e-08 | 37 | 170 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.89e-08 | 38 | 170 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 CHD7 SMARCAD1 ERVK-7 BLM DCLRE1C ERVK-8 MLH1 CHD6 DNTT | 8.60e-05 | 262 | 170 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.51e-05 | 11 | 170 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.06e-04 | 14 | 170 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.99e-04 | 38 | 170 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | lactoperoxidase activity | 4.28e-04 | 4 | 170 | 2 | GO:0140825 | |
| GeneOntologyMolecularFunction | structural molecule activity | H2BW1 ERVK-6 HSPG2 MXRA5 ABI3BP MAP2 NUMA1 ERVK-7 PXDN ACAN ERVK-8 MACF1 COL14A1 ERVK-19 ERVK-25 NEXN TNXB MYBPC3 | 6.08e-04 | 891 | 170 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.20e-04 | 21 | 170 | 3 | GO:0035613 | |
| Pubmed | 6.00e-09 | 29 | 173 | 6 | 21829377 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPS15 KLF8 TBKBP1 MAP2 NAIP FRYL NCDN PCNX2 PARP10 KMT2C INTS6 ASAP2 USF3 PXDN PTPRN2 ZNF638 MACF1 CHD6 PLCB4 TANC1 ELK4 PALS2 PATJ PRDM15 DAGLA WNK2 | 2.63e-08 | 1489 | 173 | 26 | 28611215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | GTPBP4 ABCF3 CHD7 SMARCAD1 AP3B1 IQGAP1 BLM SART1 TARDBP INTS6 NF1 MLH1 ZNF638 MACF1 HNRNPLL KNL1 | 4.13e-08 | 582 | 173 | 16 | 20467437 |
| Pubmed | RABEP2 GTPBP4 EPS15 HCN1 NUMA1 CNKSR2 CHD7 NCDN IQGAP1 SART1 CCDC88A NF1 PTPRN2 NCAN MACF1 HERC2 ARHGAP21 WNK2 LRRFIP2 FERMT3 | 8.08e-08 | 963 | 173 | 20 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 CRYBG2 TBKBP1 LMTK2 RAPGEF1 FRYL MDFI ITGA5 PCNX2 KMT2C EIF4ENIF1 SCN5A PXN TANC1 HERC2 MAPKBP1 MYRF ARHGAP21 WNK2 KLHL17 RASD2 | 1.64e-07 | 1105 | 173 | 21 | 35748872 |
| Pubmed | ABI3BP RAPGEF1 MAP3K3 KMT2C ASAP2 USF3 CCDC88A CEP95 MACF1 CHD6 HERC2 PIBF1 WNK2 SOS1 | 1.71e-07 | 486 | 173 | 14 | 20936779 | |
| Pubmed | EPS15 TSHZ3 ERP44 CHD7 PALB2 CCDC88A SALL2 EIF4ENIF1 CEP44 PXN CHD6 ARHGAP21 KNL1 | 2.01e-07 | 418 | 173 | 13 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPS15 TSHZ3 NUMA1 CNKSR2 CHD7 SMARCAD1 MAGEE1 ASAP2 USF3 EIF4ENIF1 PATJ WNK2 SOS1 | 2.77e-07 | 430 | 173 | 13 | 35044719 |
| Pubmed | EPS15 NCDN SART1 NF1 PTPRN2 STARD9 ACAN NCAN MACF1 HERC2 DAGLA PBXIP1 ARHGAP21 | 2.77e-07 | 430 | 173 | 13 | 32581705 | |
| Pubmed | STARD13 HSPG2 EPS15 FAM161B SKIL UBXN11 MACF1 ZNF76 CHD6 MPHOSPH10 HERC2 TOPORS BAG6 KNL1 SMAD6 | 3.09e-07 | 591 | 173 | 15 | 15231748 | |
| Pubmed | MXRA5 ZNF143 GAS2L3 LRRC37A3 MUC16 CHD7 ITGA5 AP3B1 AAAS NF1 PTPRN2 CHD6 MPHOSPH10 CDH17 KNL1 | 8.06e-07 | 638 | 173 | 15 | 31182584 | |
| Pubmed | EPS15 ERP44 FNDC3A HMGCR CHD7 AFAP1L1 AAAS CCDC88A EIF4ENIF1 NSFL1C PHF3 ZNF638 CHD6 TANC1 PATJ KNL1 | 9.05e-07 | 733 | 173 | 16 | 34672954 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.20e-06 | 5 | 173 | 3 | 12629516 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TBKBP1 ZNF180 TOPBP1 CHD7 SMARCAD1 BLM CCDC88A SALL2 CEP44 MACF1 TANC1 PATJ TOPORS KNL1 | 1.64e-06 | 588 | 173 | 14 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SPATA19 NUMA1 CHD7 SMARCAD1 PALB2 IQGAP1 BLM SART1 NF1 NSFL1C PHF3 ZNF638 TOPORS BAG6 CDH17 SOS1 | 1.83e-06 | 774 | 173 | 16 | 15302935 |
| Pubmed | 2.09e-06 | 225 | 173 | 9 | 12168954 | ||
| Pubmed | AKAP6 ABCF3 ERP44 GAS2L3 LMTK2 FRYL CHD7 AP3B1 NCDN MAP3K3 TARDBP KMT2C ZNF638 MACF1 MPHOSPH10 PATJ NEXN ARHGAP21 BRWD1 | 2.19e-06 | 1084 | 173 | 19 | 11544199 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 TSHZ3 NUMA1 TOPBP1 CHD7 SMARCAD1 BLM PHF3 FAM169A MLH1 CHD6 HERC2 PRDM15 BRWD1 | 2.42e-06 | 608 | 173 | 14 | 36089195 |
| Pubmed | RABEP2 TMEM51 LMTK2 PTPRU ITGA5 AP3B1 BLM TARDBP AAAS CCDC88A PTPRN2 MLH1 ZNF638 PXN TANC1 HERC2 PIBF1 KNL1 | 5.50e-06 | 1049 | 173 | 18 | 27880917 | |
| Pubmed | Exploring the link between MORF4L1 and risk of breast cancer. | 5.81e-06 | 24 | 173 | 4 | 21466675 | |
| Pubmed | CLSTN3 CNKSR2 SMARCAD1 NCDN PXDN PHF3 STARD9 MACF1 CHD6 MAPKBP1 ARHGAP21 | 6.82e-06 | 407 | 173 | 11 | 12693553 | |
| Pubmed | Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation. | 9.94e-06 | 9 | 173 | 3 | 8978305 | |
| Pubmed | 1.13e-05 | 151 | 173 | 7 | 17043677 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 GTPBP4 ABCF3 NUMA1 CHD7 SMARCAD1 IQGAP1 BLM SART1 TARDBP AAAS NF1 NSFL1C MLH1 ZNF638 MACF1 TANC1 HERC2 NEXN BAG6 | 1.45e-05 | 1353 | 173 | 20 | 29467282 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | GTPBP4 GAS2L3 TOPBP1 IQGAP1 CORO1A INTS6 PHF3 ZNF638 MPHOSPH10 HNRNPLL | 1.80e-05 | 370 | 173 | 10 | 22922362 |
| Pubmed | EPS15 TOPBP1 CHD7 AP3B1 IQGAP1 BLM KMT2C INTS6 PXDN EIF4ENIF1 PHF3 MLH1 PXN MACF1 CHD6 TANC1 MPHOSPH10 HERC2 PATJ HNRNPLL PBXIP1 | 1.90e-05 | 1497 | 173 | 21 | 31527615 | |
| Pubmed | 1.91e-05 | 32 | 173 | 4 | 20301486 | ||
| Pubmed | ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf. | 2.46e-05 | 2 | 173 | 2 | 9705341 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 28063255 | ||
| Pubmed | Direct association of Bloom's syndrome gene product with the human mismatch repair protein MLH1. | 2.46e-05 | 2 | 173 | 2 | 11691925 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 2.46e-05 | 2 | 173 | 2 | 16847056 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 21785361 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 15906353 | ||
| Pubmed | The Bloom's syndrome protein (BLM) interacts with MLH1 but is not required for DNA mismatch repair. | 2.46e-05 | 2 | 173 | 2 | 11325959 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.46e-05 | 2 | 173 | 2 | 9460924 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 16271875 | ||
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 10893243 | ||
| Pubmed | Neural progenitor cells do not differentiate prematurely in presenilin-1 null mutant mice. | 2.46e-05 | 2 | 173 | 2 | 15519767 | |
| Pubmed | 2.46e-05 | 2 | 173 | 2 | 25794620 | ||
| Pubmed | Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. | 2.46e-05 | 2 | 173 | 2 | 12881715 | |
| Pubmed | 2.57e-05 | 12 | 173 | 3 | 14557543 | ||
| Pubmed | GTPBP4 NUMA1 FRYL CHD7 IQGAP1 BLM SART1 NF1 PHF3 ZNF638 MACF1 MPHOSPH10 HERC2 | 2.59e-05 | 653 | 173 | 13 | 22586326 | |
| Pubmed | PDXDC1 BLM PHF3 MLH1 PXN MACF1 TANC1 MPHOSPH10 NEXN ARHGAP21 KNL1 | 2.69e-05 | 472 | 173 | 11 | 38943005 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP2 RIMKLA LMTK2 FRYL MAP3K3 CCDC88A NF1 PHF3 CEP95 STARD9 MACF1 TANC1 PATJ PIBF1 ARHGAP21 | 2.90e-05 | 861 | 173 | 15 | 36931259 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.94e-05 | 313 | 173 | 9 | 38270169 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | STARD13 RABEP2 ZNF143 TBKBP1 AP3B1 MAP3K3 IQGAP1 BLM SART1 CORO1A ASAP2 CCDC88A NF1 EIF4ENIF1 CEP44 ZNF638 PXN COL14A1 PIBF1 | 3.49e-05 | 1321 | 173 | 19 | 27173435 |
| Pubmed | Association of gene polymorphisms with chronic kidney disease in Japanese individuals. | 4.25e-05 | 39 | 173 | 4 | 19724895 | |
| Pubmed | GTPBP4 ISLR2 SMARCAD1 SKIL SART1 INTS6 ZNF526 SALL2 EIF4ENIF1 SCN5A MLH1 MACF1 TANC1 TOPORS KNL1 SOS1 BRWD1 | 4.56e-05 | 1116 | 173 | 17 | 31753913 | |
| Pubmed | 6.46e-05 | 16 | 173 | 3 | 17696610 | ||
| Pubmed | 7.23e-05 | 86 | 173 | 5 | 37253089 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 7.23e-05 | 86 | 173 | 5 | 28327460 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 12409258 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 30705246 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 19669783 | ||
| Pubmed | A kindlin-3-leupaxin-paxillin signaling pathway regulates podosome stability. | 7.36e-05 | 3 | 173 | 2 | 31537712 | |
| Pubmed | TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner. | 7.36e-05 | 3 | 173 | 2 | 38840222 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 21107430 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 28533432 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 17622474 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 16680194 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 9808625 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 15316014 | ||
| Pubmed | Valosin-containing protein and neurofibromin interact to regulate dendritic spine density. | 7.36e-05 | 3 | 173 | 2 | 22105171 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 10516026 | ||
| Pubmed | CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes. | 7.36e-05 | 3 | 173 | 2 | 35176204 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 26159191 | ||
| Pubmed | HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and WRN. | 7.36e-05 | 3 | 173 | 2 | 33432007 | |
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 21835156 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 31843968 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 39042440 | ||
| Pubmed | 7.36e-05 | 3 | 173 | 2 | 15315973 | ||
| Pubmed | 7.51e-05 | 140 | 173 | 6 | 26930384 | ||
| Pubmed | 8.45e-05 | 359 | 173 | 9 | 35559673 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.80e-05 | 281 | 173 | 8 | 28706196 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 9.24e-05 | 283 | 173 | 8 | 30585729 | |
| Pubmed | 9.34e-05 | 18 | 173 | 3 | 12571105 | ||
| Pubmed | 9.47e-05 | 146 | 173 | 6 | 27068509 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.10e-04 | 94 | 173 | 5 | 21542922 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PDXDC1 EPS15 ABCF3 TMEM51 IQGAP1 NSFL1C PXN MACF1 TANC1 PATJ ARHGAP21 | 1.33e-04 | 565 | 173 | 11 | 25468996 |
| Pubmed | KNL1 and the CENP-H/I/K complex coordinately direct kinetochore assembly in vertebrates. | 1.47e-04 | 4 | 173 | 2 | 18045986 | |
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 27350668 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 12149250 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 17651422 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 26428891 | ||
| Pubmed | Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. | 1.47e-04 | 4 | 173 | 2 | 21747167 | |
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 11470874 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.47e-04 | 4 | 173 | 2 | 10469592 | |
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 25982384 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 17053831 | ||
| Pubmed | Gene replacement-Alzheimer's disease (GR-AD): Modeling the genetics of human dementias in mice. | 1.47e-04 | 4 | 173 | 2 | 38343132 | |
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 7983737 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 10766023 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 36631800 | ||
| Pubmed | 1.47e-04 | 4 | 173 | 2 | 24573678 | ||
| Pubmed | An Alternative Splicing Program for Mouse Craniofacial Development. | 1.51e-04 | 21 | 173 | 3 | 33013468 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.55e-04 | 101 | 173 | 5 | 20551380 | |
| Pubmed | 1.62e-04 | 102 | 173 | 5 | 26584622 | ||
| Pubmed | 1.67e-04 | 231 | 173 | 7 | 19060904 | ||
| Pubmed | 1.67e-04 | 162 | 173 | 6 | 15174051 | ||
| GeneFamily | Fibronectin type III domain containing | 7.34e-05 | 160 | 115 | 7 | 555 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.39e-04 | 4 | 115 | 2 | 574 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.75e-04 | 161 | 115 | 6 | 593 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 8.12e-04 | 29 | 115 | 3 | 396 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.40e-03 | 9 | 115 | 2 | 1203 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.04e-03 | 206 | 115 | 6 | 682 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.24e-03 | 41 | 115 | 3 | 1298 | |
| GeneFamily | UBX domain containing | 2.99e-03 | 13 | 115 | 2 | 364 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.99e-03 | 15 | 115 | 2 | 759 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.66e-03 | 53 | 115 | 3 | 532 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 5.12e-03 | 17 | 115 | 2 | 1197 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | KLF8 TSHZ3 ZNF143 IKZF2 ZNF180 ZFY ZNF526 PRDM10 SALL2 ZNF76 PRDM15 | 6.04e-03 | 718 | 115 | 11 | 28 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | GAS2L3 TOPBP1 SKIL CENPK PRMT6 CEP44 MALSU1 PRDM15 KNL1 BRWD1 | 5.60e-07 | 195 | 168 | 10 | M13736 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | STARD13 EPS15 TOPBP1 FNDC3A FRYL BLM ASAP2 PHF3 FAM169A ZNF638 PALS2 PIBF1 SOS1 | 1.05e-05 | 466 | 168 | 13 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 EPS15 PHF20 TOPBP1 FNDC3A FRYL AP3B1 BLM ASAP2 PHF3 FAM169A ZNF638 MACF1 PLCB4 PALS2 PIBF1 SMAD6 SOS1 | 1.05e-05 | 856 | 168 | 18 | M4500 |
| Coexpression | NABA_CORE_MATRISOME | 1.20e-05 | 275 | 168 | 10 | M5884 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.21e-05 | 180 | 168 | 8 | M8239 | |
| Coexpression | GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP | 2.69e-05 | 185 | 168 | 8 | M7592 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 4.68e-05 | 200 | 168 | 8 | M6447 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | GTPBP4 EPS15 ZNF143 KIAA0586 TOPBP1 FNDC3A CHD7 AP3B1 CENPK SART1 ASAP2 DCLRE1C MLH1 MACF1 KNL1 SOS1 BRWD1 | 2.02e-06 | 564 | 165 | 17 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | GTPBP4 KIAA0586 CHD7 AP3B1 BLM USF3 CCDC88A MPHOSPH10 PIBF1 ARHGAP21 LRRFIP2 KNL1 | 6.04e-06 | 311 | 165 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.78e-05 | 220 | 165 | 9 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_1000 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDXDC1 IKZF2 LMTK2 MUC16 CMYA5 MACF1 TANC1 PATJ ARHGAP21 WNK2 | 1.69e-09 | 179 | 168 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-09 | 195 | 168 | 10 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AKAP6 CMYA5 CCDC88A ZNF638 MACF1 COL14A1 ELK4 PIBF1 ARHGAP21 | 2.42e-08 | 176 | 168 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.55e-08 | 184 | 168 | 9 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.68e-08 | 190 | 168 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.90e-08 | 191 | 168 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-08 | 192 | 168 | 9 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.12e-08 | 192 | 168 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.85e-08 | 195 | 168 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.97e-08 | 199 | 168 | 9 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.80e-07 | 170 | 168 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.15e-07 | 179 | 168 | 8 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.91e-07 | 183 | 168 | 8 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 5.11e-07 | 184 | 168 | 8 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.33e-07 | 185 | 168 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 5.78e-07 | 187 | 168 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 5.78e-07 | 187 | 168 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.02e-07 | 188 | 168 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.26e-07 | 189 | 168 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.26e-07 | 189 | 168 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-07 | 189 | 168 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-07 | 189 | 168 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-07 | 190 | 168 | 8 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.52e-07 | 190 | 168 | 8 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.52e-07 | 190 | 168 | 8 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.78e-07 | 191 | 168 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.34e-07 | 193 | 168 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.63e-07 | 194 | 168 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.63e-07 | 194 | 168 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.24e-07 | 196 | 168 | 8 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.89e-07 | 198 | 168 | 8 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 8.89e-07 | 198 | 168 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 168 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 168 | 8 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.24e-07 | 199 | 168 | 8 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-06 | 145 | 168 | 7 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-06 | 162 | 168 | 7 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.92e-06 | 163 | 168 | 7 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.92e-06 | 163 | 168 | 7 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 3.29e-06 | 166 | 168 | 7 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.70e-06 | 169 | 168 | 7 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-06 | 170 | 168 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-06 | 172 | 168 | 7 | bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.32e-06 | 173 | 168 | 7 | 5c55e1e27e9e3e77600d378cc87b51cc73907527 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-06 | 175 | 168 | 7 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 179 | 168 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 5.40e-06 | 179 | 168 | 7 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 5.81e-06 | 181 | 168 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-06 | 181 | 168 | 7 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.81e-06 | 181 | 168 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.03e-06 | 182 | 168 | 7 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.47e-06 | 184 | 168 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.47e-06 | 184 | 168 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.71e-06 | 185 | 168 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 186 | 168 | 7 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-06 | 186 | 168 | 7 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 6.95e-06 | 186 | 168 | 7 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.20e-06 | 187 | 168 | 7 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 187 | 168 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 187 | 168 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 187 | 168 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.45e-06 | 188 | 168 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 7.45e-06 | 188 | 168 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 7.45e-06 | 188 | 168 | 7 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.45e-06 | 188 | 168 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.71e-06 | 189 | 168 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.71e-06 | 189 | 168 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.98e-06 | 190 | 168 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.98e-06 | 190 | 168 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 191 | 168 | 7 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 192 | 168 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.14e-06 | 194 | 168 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.46e-06 | 195 | 168 | 7 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.78e-06 | 196 | 168 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.78e-06 | 196 | 168 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.78e-06 | 196 | 168 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 197 | 168 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 197 | 168 | 7 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 198 | 168 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.04e-05 | 198 | 168 | 7 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.08e-05 | 199 | 168 | 7 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.08e-05 | 199 | 168 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 199 | 168 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-05 | 199 | 168 | 7 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-05 | 199 | 168 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | RABEP2 AP3B1 PRDM10 FAM169A ZNF638 PXN MACF1 ELK4 MAPKBP1 SMAD6 | 2.17e-06 | 196 | 169 | 10 | 5294_DN |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; HL60; HT_HG-U133A | TBKBP1 NUMA1 ASAP2 NF1 PTPRN2 SCN5A SLC17A7 MYRF BRWD1 MYBPC3 | 2.60e-06 | 200 | 169 | 10 | 2141_UP |
| Disease | docosapentaenoic acid measurement | 1.43e-05 | 27 | 163 | 4 | EFO_0006809 | |
| Disease | Hypermetropia | 2.38e-05 | 103 | 163 | 6 | HP_0000540 | |
| Disease | Primary dilated cardiomyopathy | 3.66e-05 | 34 | 163 | 4 | cv:C0007193 | |
| Disease | sexual dimorphism measurement | PDXDC1 PHF20 EFCAB13 FRYL HMGCR AP3B1 MAP3K3 SART1 PARP10 CORO1A NF1 ACAN ZNF638 MACF1 MAPKBP1 PATJ MYRF MYBPC3 | 4.31e-05 | 1106 | 163 | 18 | EFO_0021796 |
| Disease | Osteopetrosis Autosomal Dominant Type 2 | 9.07e-05 | 3 | 163 | 2 | C3179239 | |
| Disease | Congenital Osteopetrosis | 9.07e-05 | 3 | 163 | 2 | C3645711 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 9.07e-05 | 3 | 163 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 1.03e-04 | 44 | 163 | 4 | C0340427 | |
| Disease | PR interval | AKAP6 EFCAB5 HSPG2 EPS15 CRYBG2 HCN1 UBXN11 CEP95 SCN5A MACF1 CHD6 | 1.03e-04 | 495 | 163 | 11 | EFO_0004462 |
| Disease | Cardiomyopathy | 1.33e-04 | 47 | 163 | 4 | cv:C0878544 | |
| Disease | Omenn Syndrome | 1.50e-04 | 19 | 163 | 3 | C2700553 | |
| Disease | Colorectal Carcinoma | AKAP6 CLSTN3 MAP2 CNKSR2 PTPRU ADARB2 NCDN MFN1 KMT2C NF1 PTPRN2 MLH1 TSKS | 1.51e-04 | 702 | 163 | 13 | C0009402 |
| Disease | Osteopetrosis | 3.00e-04 | 5 | 163 | 2 | C0029454 | |
| Disease | antiphospholipid syndrome | 3.08e-04 | 24 | 163 | 3 | EFO_0002689 | |
| Disease | alpha-linolenic acid measurement | 3.48e-04 | 25 | 163 | 3 | EFO_0007759 | |
| Disease | bipolar disorder | AKAP6 MAP2 CNKSR2 PALB2 PARP10 ASAP2 STARD9 SCN2A NCAN PALS2 WNK2 | 3.84e-04 | 577 | 163 | 11 | MONDO_0004985 |
| Disease | level of Phosphatidylcholine (18:1_20:3) in blood serum | 4.48e-04 | 6 | 163 | 2 | OBA_2045103 | |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 4.48e-04 | 6 | 163 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | wheezing | 4.67e-04 | 65 | 163 | 4 | EFO_0009715 | |
| Disease | FEV/FEC ratio | AKAP6 STARD13 EFCAB5 HSPG2 TSHZ3 MAP2 HCN1 KIAA0586 CNKSR2 AFAP1L1 FRMD4A CORO1A ASAP2 ACAN NEXN TNXB SMAD6 | 4.75e-04 | 1228 | 163 | 17 | EFO_0004713 |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.12e-04 | 118 | 163 | 5 | EFO_0010119 | |
| Disease | Developmental Academic Disorder | 5.44e-04 | 29 | 163 | 3 | C1330966 | |
| Disease | Learning Disorders | 5.44e-04 | 29 | 163 | 3 | C0023186 | |
| Disease | Learning Disturbance | 5.44e-04 | 29 | 163 | 3 | C0751263 | |
| Disease | Adult Learning Disorders | 5.44e-04 | 29 | 163 | 3 | C0751262 | |
| Disease | Learning Disabilities | 5.44e-04 | 29 | 163 | 3 | C0751265 | |
| Disease | congenital heart disease (implicated_via_orthology) | 5.87e-04 | 69 | 163 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Frontotemporal dementia | 6.25e-04 | 7 | 163 | 2 | C0338451 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 6.25e-04 | 7 | 163 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | 6.33e-04 | 517 | 163 | 10 | EFO_0010554 | |
| Disease | Prostatic Neoplasms | ERP44 PON1 LMTK2 CHD7 SMARCAD1 PALB2 KMT2C AAAS MLH1 CHD6 PATJ | 6.61e-04 | 616 | 163 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | ERP44 PON1 LMTK2 CHD7 SMARCAD1 PALB2 KMT2C AAAS MLH1 CHD6 PATJ | 6.61e-04 | 616 | 163 | 11 | C0376358 |
| Disease | eicosapentaenoic acid measurement | 6.64e-04 | 31 | 163 | 3 | EFO_0007760 | |
| Disease | waist circumference | 6.67e-04 | 429 | 163 | 9 | EFO_0004342 | |
| Disease | Cardiomyopathies | 7.94e-04 | 130 | 163 | 5 | C0878544 | |
| Disease | migraine disorder | 8.69e-04 | 357 | 163 | 8 | MONDO_0005277 | |
| Disease | phosphatidylcholine measurement | 1.06e-03 | 284 | 163 | 7 | EFO_0010226 | |
| Disease | corticobasal degeneration disorder | 1.06e-03 | 9 | 163 | 2 | MONDO_0022308 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.06e-03 | 9 | 163 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.06e-03 | 9 | 163 | 2 | OBA_2045130 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 1.06e-03 | 9 | 163 | 2 | EFO_0800271 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.06e-03 | 9 | 163 | 2 | C3502809 | |
| Disease | apolipoprotein B measurement | TBKBP1 PSEN1 ZNF180 EFCAB13 HMGCR IQGAP1 PARP10 NF1 NCAN MYRF BRWD1 | 1.20e-03 | 663 | 163 | 11 | EFO_0004615 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.33e-03 | 10 | 163 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Asthma, Occupational | 1.33e-03 | 10 | 163 | 2 | C0264423 | |
| Disease | Bipolar Disorder | 1.40e-03 | 477 | 163 | 9 | C0005586 | |
| Disease | Lymphoma | 1.41e-03 | 40 | 163 | 3 | C0024299 | |
| Disease | cardiac troponin T measurement | 1.41e-03 | 219 | 163 | 6 | EFO_0005043 | |
| Disease | lysophosphatidylethanolamine measurement | 1.51e-03 | 41 | 163 | 3 | EFO_0010225 | |
| Disease | thrombin generation potential measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0005538 | |
| Disease | phospholipids:total lipids ratio | 1.69e-03 | 227 | 163 | 6 | EFO_0020946 | |
| Disease | cystatin C measurement | 1.84e-03 | 402 | 163 | 8 | EFO_0004617 | |
| Disease | cholesteryl ester 20:5 measurement | 1.86e-03 | 44 | 163 | 3 | EFO_0010349 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.93e-03 | 12 | 163 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.93e-03 | 12 | 163 | 2 | EFO_0800500 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 1.93e-03 | 12 | 163 | 2 | OBA_2045115 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.93e-03 | 12 | 163 | 2 | OBA_2045157 | |
| Disease | dementia (is_implicated_in) | 1.93e-03 | 12 | 163 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.98e-03 | 45 | 163 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | colorectal cancer | AKAP6 STARD13 EIF4ENIF1 PTPRN2 MLH1 MACF1 TANC1 HERC2 MYRF SMAD6 | 2.02e-03 | 604 | 163 | 10 | MONDO_0005575 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.25e-03 | 99 | 163 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 2.27e-03 | 13 | 163 | 2 | EFO_0800547 | |
| Disease | Hyperlipoproteinemia Type IIb | 2.27e-03 | 13 | 163 | 2 | C1704417 | |
| Disease | cognitive function measurement | GABRB1 AKAP6 EFCAB5 TMEM51 FAM161B CHD7 FRMD4A ASAP2 PTPRN2 SCN2A ZNF638 TNXB ARHGAP21 WNK2 CDH17 SOS1 MYBPC3 | 2.53e-03 | 1434 | 163 | 17 | EFO_0008354 |
| Disease | JT interval | 2.63e-03 | 248 | 163 | 6 | EFO_0007885 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.64e-03 | 14 | 163 | 2 | EFO_0800173 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 2.64e-03 | 14 | 163 | 2 | EFO_0022085 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 2.64e-03 | 14 | 163 | 2 | EFO_0021462 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.68e-03 | 50 | 163 | 3 | EFO_0010732 | |
| Disease | phosphatidylethanolamine measurement | 2.80e-03 | 173 | 163 | 5 | EFO_0010228 | |
| Disease | Leukemia, Myelocytic, Acute | 2.80e-03 | 173 | 163 | 5 | C0023467 | |
| Disease | fatty acid measurement | 3.03e-03 | 436 | 163 | 8 | EFO_0005110 | |
| Disease | P wave duration | 3.04e-03 | 15 | 163 | 2 | EFO_0005094 | |
| Disease | RASopathy | 3.04e-03 | 15 | 163 | 2 | cv:C5555857 | |
| Disease | eosinophil measurement | 3.08e-03 | 108 | 163 | 4 | EFO_0803540 | |
| Disease | cholesteryl ester measurement | 3.14e-03 | 257 | 163 | 6 | EFO_0010351 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.17e-03 | 53 | 163 | 3 | EFO_0022340 | |
| Disease | cortical surface area measurement | RABEP2 EFCAB5 MAP2 PKDCC FRYL HMGCR CHD7 SMARCAD1 AFAP1L1 CCDC88A MLH1 MACF1 TNXB ARHGAP21 WNK2 SOS1 | 3.27e-03 | 1345 | 163 | 16 | EFO_0010736 |
| Disease | tonsillectomy risk measurement | 3.32e-03 | 260 | 163 | 6 | EFO_0007924 | |
| Disease | asthma, response to diisocyanate | 3.38e-03 | 261 | 163 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.46e-03 | 16 | 163 | 2 | C0745103 | |
| Disease | filaggrin gene expression measurement | 3.46e-03 | 16 | 163 | 2 | EFO_0020899 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 3.46e-03 | 16 | 163 | 2 | OBA_2045093 | |
| Disease | multiple myeloma | 3.51e-03 | 112 | 163 | 4 | EFO_0001378 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.70e-03 | 56 | 163 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 3.70e-03 | 56 | 163 | 3 | EFO_0022250 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 3.89e-03 | 57 | 163 | 3 | EFO_0022284 | |
| Disease | cholesterol in IDL measurement | 4.09e-03 | 58 | 163 | 3 | EFO_0021899 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.29e-03 | 59 | 163 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 4.29e-03 | 59 | 163 | 3 | EFO_0022289 | |
| Disease | body weight | GABRB1 AKAP6 PDXDC1 ZNF143 CNKSR2 CHD7 AP3B1 PRMT6 CORO1A USF3 PHF3 ACAN ZNF638 PATJ HNRNPLL | 4.38e-03 | 1261 | 163 | 15 | EFO_0004338 |
| Disease | left ventricular mass | 4.38e-03 | 18 | 163 | 2 | EFO_0009289 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 4.38e-03 | 18 | 163 | 2 | OBA_2045065 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 4.38e-03 | 18 | 163 | 2 | OBA_2045079 | |
| Disease | Hypercholesterolemia, Familial | 4.38e-03 | 18 | 163 | 2 | C0020445 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 4.50e-03 | 60 | 163 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | free cholesterol in IDL measurement | 4.71e-03 | 61 | 163 | 3 | EFO_0022181 | |
| Disease | Lewy body dementia (is_marker_for) | 4.88e-03 | 19 | 163 | 2 | DOID:12217 (is_marker_for) | |
| Disease | skin sensitivity to sun | 4.88e-03 | 19 | 163 | 2 | EFO_0004795 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSESNLEDSIAVGPI | 371 | Q13075 | |
| LSETTIQTPDGEERL | 381 | Q9NRG9 | |
| AQELGDTTTLEDPSI | 656 | Q9NUB1 | |
| DTPVIDITLDVESSS | 601 | Q8NEM8 | |
| QVSPAVDSDLTESLD | 286 | O71037 | |
| QVSPAVDSDLTESLD | 286 | Q902F8 | |
| PSQSLLTLEGDDVET | 571 | Q9BQT9 | |
| STSTAVEEPDSLEVL | 6 | P46379 | |
| QSEGFPVIETSTLTE | 311 | Q9BZE4 | |
| DDTPALQSVLESDSV | 246 | Q9NUQ8 | |
| EDNVDISEDTLSPIT | 181 | Q9C0F1 | |
| ISEDTLSPITDVNEA | 186 | Q9C0F1 | |
| EEPLSLQELDTSSGV | 256 | P31146 | |
| GSEDITTSPQLSKED | 2376 | Q9P2D1 | |
| SEPVLTEEDATSLIT | 1281 | P58397 | |
| EATELGQEATSTISP | 16 | O00203 | |
| SILGETETEPEEDTS | 426 | Q6UXK2 | |
| GETLTEILETPATSE | 1401 | P46940 | |
| GLSLPEDIETVTASQ | 31 | P98160 | |
| SPDSVDRVLSEGSEV | 991 | Q9H0J4 | |
| LSPEQEETASLVSTG | 256 | Q9H5N1 | |
| PGITNTEDDDTLSTS | 51 | Q9NS39 | |
| STSSESEPELGEIRD | 346 | Q8IXN7 | |
| VESEQLTGVPLDDSA | 181 | Q9UL03 | |
| GPSSETTSEEQLITQ | 31 | Q7Z2G1 | |
| SVVPSQIFELEDGTS | 411 | Q8WVV9 | |
| ASEEGDDSLLITVVP | 161 | Q0ZGT2 | |
| PESSLSSEEETAGVE | 431 | Q92932 | |
| LVDSPGTDVTTELDS | 176 | Q8IWA4 | |
| SGDSAPVELILSDET | 291 | P04217 | |
| TPSLEQGDTQSELLD | 61 | Q96LL4 | |
| TDTLSREIETGPTNI | 1611 | Q8WXI7 | |
| SETTDIEGEPTSSLT | 4586 | Q8WXI7 | |
| TEETSTQLPDLGLAI | 741 | O60309 | |
| DKGDITTDPTEIQTT | 396 | O00370 | |
| LPDTLVDESVSVTES | 1326 | Q8NEZ4 | |
| PVEDTSNDESSILGT | 191 | Q8TC57 | |
| ATEGLSTSVQATPDE | 216 | Q9HCI5 | |
| DTSVLPDSVEIGLQT | 506 | Q9UBB6 | |
| DQEIVTIPDLGSLSS | 1286 | O95714 | |
| SLLDTSSVLVTQEPE | 421 | P04035 | |
| SIEIANESGETPLDI | 646 | O43150 | |
| TGSTENLEVPDDIST | 1506 | Q3V6T2 | |
| SSGPLELSAQETVED | 156 | A6NKB5 | |
| DSEVAVTLIDTSQPG | 351 | A6NKB5 | |
| SSGPEQITLEASSTE | 736 | Q6P996 | |
| ELVSELQLTDPVSSG | 1441 | O94915 | |
| LEIPSDSEESTIESG | 226 | O95600 | |
| ISEEGTPVLEEASST | 1351 | O94854 | |
| SETINDEDISLLPES | 96 | O00566 | |
| LSPEEEIDSTSDSTG | 51 | Q96MY7 | |
| VTGIDDLEQIPADTT | 1691 | Q8NG31 | |
| SPGESEETLRLTESD | 886 | Q8IWU2 | |
| NETSGSEVLTSVSDP | 376 | P18505 | |
| ATLETESGELVPTEL | 566 | Q2TBA0 | |
| IESVDGSDPLATLQT | 111 | Q9NQV6 | |
| VVTEELLTLPSNGES | 436 | Q7Z3K6 | |
| ISIESREEEITSPGS | 81 | Q6UWI2 | |
| GDEDIVTISQATPSS | 46 | Q9UNZ2 | |
| EGSSLEEPLIESSEV | 76 | Q9UKS7 | |
| QVSPAVDSDLTESLD | 1046 | P63135 | |
| DGTTLSLTSPESTEE | 16 | A6NMN3 | |
| SEPVSAATTQTLEGD | 256 | Q9NQS5 | |
| SVVSEVDDISIPDLS | 276 | Q9Y608 | |
| VETSASGIEDVSELP | 1496 | P16112 | |
| TISLAQGTPEELTFE | 471 | Q7Z442 | |
| TDEDVPSGIAAESLT | 481 | Q92729 | |
| SVESLLDELESSVPS | 216 | P49023 | |
| VEQTETAELPASDSI | 836 | Q86YC2 | |
| LESSLSSSEGEEPVE | 121 | P08648 | |
| ENLTELPSSTGAEEI | 6 | Q9NZW5 | |
| PQDTEVLIGTSTTLE | 336 | A1KZ92 | |
| LGQETLTEIQTSPET | 581 | O60353 | |
| LEDEDSQVTSTISPL | 551 | Q9P2Q2 | |
| ESVIEPGTHTESTLE | 541 | A4FU69 | |
| TGTVNEDSSEIILDP | 196 | O60741 | |
| LVSSDSLNVPSEEEV | 241 | Q6TDP4 | |
| ESLSSDPEVLLQIDG | 1251 | P54132 | |
| EIETPTQISLVDEAS | 86 | Q96SD1 | |
| QVSPAVDSDLTESLD | 286 | P61570 | |
| QVSPAVDSDLTESLD | 286 | Q69384 | |
| PSSEETIQALETLVS | 216 | P28324 | |
| TVESLELDQGLTNPS | 206 | Q8TD26 | |
| EASDPVTGQETTLAL | 521 | Q05707 | |
| ELEETLLNTSGPEDS | 186 | Q86XJ1 | |
| SLINGETDESSVPEL | 291 | Q9Y2H6 | |
| VVPQDILSEELSSES | 3431 | Q8N3K9 | |
| ILSEELSSESTPEDV | 3436 | Q8N3K9 | |
| LDPDSTTDVGDVTNT | 6 | Q9BS16 | |
| EASTESQLVSDPTEG | 731 | Q8N1P7 | |
| VEQDTDVSGEITLLP | 331 | Q96LA8 | |
| VEDTETLSVSGIPNA | 236 | Q96GE4 | |
| PEELGASISVTTDEL | 1131 | Q9NSI6 | |
| DVSITEGSPLNEITS | 291 | Q8IY85 | |
| ETSTALPQSSLIEVE | 581 | Q9Y6X4 | |
| QGLDSTDLDVPTEAV | 71 | Q99750 | |
| PVTTEITSLDTENID | 26 | Q9BS26 | |
| ILGIEDDTSSVTPVE | 216 | Q96EH3 | |
| EDSESTEPLSVDGIS | 1016 | O60336 | |
| TEPLSVDGISSDLEE | 1021 | O60336 | |
| SELPEEVEVTTLAST | 566 | Q9Y4D2 | |
| QVSPAVDSDLTESLD | 286 | Q902F9 | |
| LLPSGVTDENEVTTA | 566 | P42566 | |
| LEENTEVTSSGSLTP | 51 | Q8IXQ9 | |
| GSTILTIQATDADEP | 466 | Q12864 | |
| PEGEATSVTLVEELS | 881 | Q9Y467 | |
| GQSFLTEEEEIPSES | 626 | Q86V97 | |
| TSINSEGEFIPETSE | 196 | Q99759 | |
| ESRPSLSLGTITDEE | 1941 | Q14980 | |
| TATLDTGLEEVDPTE | 551 | Q53GL7 | |
| VSDLVDTDPLQDTLS | 346 | Q9BVI0 | |
| EQEPAVSSDSDISLI | 401 | Q9ULK6 | |
| ETAAPSETEETLNTG | 271 | C9JL84 | |
| TSSESVLTDLSEPEV | 181 | Q9Y3M8 | |
| GIETSDIADVPSDTS | 856 | Q15147 | |
| DSEDIPDTLTTITEL | 221 | Q504Y2 | |
| TLVDNISVDPETGDL | 266 | P27169 | |
| VQELSSSILAGEDPE | 361 | P49768 | |
| TETEATNSLITAPGE | 301 | O43541 | |
| IIVSEPSEDEESQGL | 121 | Q9H4L7 | |
| IPSDSSTELTQTVLE | 136 | P12757 | |
| IEIPSEDDGTVLLST | 16 | Q13148 | |
| FLITSPGSTEDEEQL | 346 | P04053 | |
| LETSLGNEVSDTEPL | 151 | P57071 | |
| DLSQTDPGEQTLTIE | 111 | Q7RTZ1 | |
| DTSIVTPLTTLEQGD | 866 | O14594 | |
| STTLQESREGLPEEE | 36 | Q14524 | |
| DLDSNPGEDTTEIVT | 571 | Q8IUH8 | |
| PVAEEETTGSAESTL | 271 | Q9C0D5 | |
| ETLELSADGRPVTTQ | 31 | Q9P2U7 | |
| TVDEGSQTDLTLPTL | 3731 | Q9P2P6 | |
| EDGSTPERVASLDTV | 256 | A8MXQ7 | |
| STLDTELTPINGTEE | 6 | Q96LB2 | |
| ISEESTLSGQQSEVP | 691 | P40692 | |
| LSLTDEEPSTSGEQT | 186 | Q07889 | |
| PTSQSETIELTGFDD | 226 | Q9NRA8 | |
| SIESGPLSDILSDEE | 711 | Q13023 | |
| LADDLQTSSTEEEVP | 406 | Q8TED9 | |
| SNDPLSISSEVDVIT | 1006 | Q8WXI2 | |
| LPITSSDIDVVESEA | 21 | Q7Z5L4 | |
| TGDATIDPDTISALE | 171 | P52747 | |
| ESPQSGSILTEETEV | 66 | Q96AQ6 | |
| SQSTELLPDATDEEV | 251 | Q13905 | |
| SSIEDQSGTEPISSE | 1341 | Q8NI35 | |
| EGISTSSLEVVPENL | 686 | Q5T4T6 | |
| LEELTVTDATPDSLS | 2306 | P22105 | |
| SSLESEDISLETTVP | 16 | Q8WXW3 | |
| EDISLETTVPTDDIS | 21 | Q8WXW3 | |
| TLIGTETVTPDEQFT | 801 | Q92626 | |
| AGQLLPEGTTTETEI | 666 | Q99250 | |
| GLDETTPTSTRADVE | 166 | Q9NW97 | |
| IDEETSEESLLTPTS | 2746 | P21359 | |
| LEVVDTSTFGPESNI | 421 | Q92576 | |
| VPTTEAELLVSGDEN | 151 | Q96D21 | |
| ISAQSILELPTSESE | 231 | Q68DE3 | |
| ILELPTSESESNVLG | 236 | Q68DE3 | |
| DPEAESVTLRVTGES | 26 | Q86UX7 | |
| EPTDSTGTDSTVEDL | 91 | Q9UJT2 | |
| SASSTTILDEEPIVN | 621 | O43290 | |
| EVTVPLEDTTVSDSL | 101 | Q63HK5 | |
| PASEQTVTVEEDLLT | 141 | P11137 | |
| LVDNIELASTSSPEE | 381 | Q0D2K0 | |
| GEEISIEVSNPSLLD | 286 | O14788 | |
| VEGEDTGSLTIPSQE | 56 | Q9UJW8 | |
| TPELVELSSDSEDLG | 491 | Q9NS56 | |
| TELGETIAIIETSQP | 626 | Q8TF50 | |
| RSQLETPETLLGSTE | 431 | P20333 | |
| QGLTSELETSQPLAE | 1461 | Q9Y3S1 | |
| GEELENITDFSSSPT | 766 | Q7Z7G0 | |
| SLEPEESLDVSETEG | 276 | P57768 | |
| LISEGRPVETDSESE | 1626 | Q5T5U3 | |
| EDDISILTQEALGPS | 6 | A7MCY6 | |
| VPDVSTITEEGLFSQ | 541 | Q92547 | |
| ELEEESTPSIQTETL | 1126 | Q14966 | |
| DPSTLEAVQLEDGST | 81 | P36508 | |
| EEISTEITNGPLISL | 371 | A6NCI4 | |
| SETSEPLTSDIVEGT | 956 | Q9BVV6 | |
| DLSELVVEGDTQVTP | 206 | Q5T124 | |
| SVVEAEIITDPLTSD | 156 | P08048 | |
| EGQESKSITLPDSTL | 1086 | Q9NR99 | |
| GEEVSIRNSPTDTIL | 1016 | Q14896 | |
| GALEPSNIDTSILEE | 21 | Q9Y2G1 |